INHIBITEURS DE LA DIPEPTIDYL-PEPTIDASE IV COMPRENANT UNE PYRROLIDINE ET UN CYCLOPROPYLE FUSIONNÉS ET LEUR UTILISATION PHARMACEUTIQUE

• 收藏
• 分享

专利权人:

AstraZeneca AB

发明人:

申请号：

EP15186007.9

公开号：

EP2995615A1

申请日:

2001.03.05

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

Dipeptidyl peptidase IV (DP 4) inhibiting compounds are provided. The provided compounds can be used for treating diabetes and related diseases, especially Type II diabetes, and other diseases as set out herein, employing such DP 4 inhibitor or a combination of such DP 4 inhibitor and one or more of another antidiabetic agent such as metformin, glyburide, troglitazone, pioglitazone, rosiglitazone and/or insulin and/or one or more of a hypolipidemic agent and/or anti-obesity agent and/or other therapeutic agent.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/